Changes in united network for organ sharing policy for simultaneous liver‐kidney allocation
Jonathan Merola, Richard N. Formica, David C. Mulligan – 3 February 2017
Developing a liver cancer program in the nonacademic medical center
Kent Benner, Ken Flora, Pippa Newell – 3 February 2017
Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil
Delia D'Avola, Valentín Cuervas‐Mons, Josep Martí, Jorge Ortiz de Urbina, Laura Lladó, Carlos Jimenez, Esteban Otero, Francisco Suarez, Juan M. Rodrigo, Miguel‐Angel Gómez, Enrique Fraga, Pedro Lopez, M. Trinidad Serrano, Antonio Rios, Emilio Fábrega, José Ignacio Herrero – 3 February 2017 – Cardiovascular (CV) diseases are recognized longterm causes of death after liver transplantation (LT). The objective of this multicenter study was to analyze the prevalence and the evolution of CV risk factors and CV morbidity and mortality in 1819 LT recipients along 5 years after LT.
Thrombosis and coagulopathy in the liver transplant candidate and recipient
R. Todd Stravitz – 3 February 2017
Developing a liver cancer program in the nonacademic medical center
Kent Benner, Ken Flora, Pippa Newell – 3 February 2017
Elastography to assess the stage of liver fibrosis in children: Concepts, opportunities, and challenges
Suraj D. Serai, Andrew T. Trout, Claude B. Sirlin – 3 February 2017
The highly sensitized, high MELD, simultaneous liver‐kidney or status 1A heart‐liver transplant candidate
Timucin Taner – 3 February 2017
Elastography to assess the stage of liver fibrosis in children: Concepts, opportunities, and challenges
Suraj D. Serai, Andrew T. Trout, Claude B. Sirlin – 3 February 2017
Liver fat accumulation as a barometer of insulin responsiveness again points to adipose tissue as the culprit
Yaron Rotman, Brent A. Neuschwander‐Tetri – 2 February 2017
Changing pattern of biliary complications in an evolving liver transplant unit
Ashwin Rammohan, Sanjay Govil, Joy Vargese, Venugopal Kota, Mettu S. Reddy, Mohamed Rela – 2 February 2017 – Biliary complications (BCs) remain a significant cause of morbidity following liver transplantation (LT). This series of 640 LT recipients with a blend of living and deceased donor transplants was analyzed to determine the incidence, risk factors, management protocol, and outcomes in these patients. Review of a prospectively collected database of transplant recipients operated between August 2009 and June 2016 was performed.